Charlene Hualing Cheng
About Charlene Hualing Cheng
Charlene Hualing Cheng is the Director Of Compliance at BeiGene in Shanghai, with over 14 years of experience in compliance, internal audit, and process improvement.
Title and Current Position
Charlene Hualing Cheng is currently serving as the Director Of Compliance at BeiGene in Shanghai, China. With extensive experience in the field, she plays a crucial role in overseeing compliance measures and ensuring adherence to industry regulations.
Professional Experience at Novartis
Charlene Hualing Cheng worked at Novartis for an extensive period, holding multiple roles. She served as a Compliance Officer from 2016 to 2022 in Shanghai, focusing on compliance risk management. Prior to that, from 2014 to 2016, she was the Compliance Manager/Sr. Manager for Monitoring in Shanghai, where she was responsible for overseeing monitoring processes and enhancing compliance frameworks.
Previous Positions and Responsibilities
Charlene has held several key positions in her career. From 2012 to 2014, she was the Internal Audit Supervisor at Houghton in Shanghai. She also worked as the Senior Internal Auditor at Sunningdale Tech Ltd from 2011 to 2012 for five months. Earlier in her career, Charlene was a Senior Auditor at Ernst & Young from 2008 to 2010 and an Auditor at KPMG from 2006 to 2008, both in Shanghai.
Educational Background and Certifications
Charlene holds a Master of Science in Accountancy from the University of Illinois at Urbana-Champaign, completed in 2011. She also earned a Bachelor's Degree in Economics and Finance from 上海对外经贸大学, completed in 2006. Additionally, she holds the Certified Internal Auditor (CIA) designation, underscoring her expertise in internal auditing and compliance.
Industry Experience and Contributions
With over 14 years of experience, Charlene Hualing Cheng has significantly contributed to the fields of compliance, internal audit, internal control, and process improvement. She has worked extensively in the healthcare industry, managing compliance risks for multinational corporations and helping them enhance their internal control and business processes.